Despite the high long-term survival in localized prostate cancer, metastatic prostate cancer
remains largely incurable even after intensive multimodal therapy. The lethality of advanced …

Goh CL, Schumacher FR, Easton D, Muir K, Henderson B, Kote‐Jarai Z, Eeles RA (The
Institute of Cancer Research, Sutton, Surrey, UK; Keck School of Medicine, University of …

Prostate cancer (PCa) represents the most commonly non-cutaneous diagnosed cancer in
men worldwide and occupies a very wide area of preclinical and clinical research. Targeted …

The inherited link of prostate cancer predisposition has been supported using data from
early epidemiological studies, as well as from familial and twin studies. Early linkage …

B. Perbal identification and scoring of the molecular signaling events in which CCN proteins
and their partners are involved, and how they are altered or amplified in normal and …

Serin proteazlar, hücre büyümesi ve farklılaşmasında önemli rolü olan bir grup proteazdır.
İnsanlarda tahmin edilen 175 üyeden oluşur. Bunların çoğu salgılanan proteazlardır …

Several studies have linked sexually transmitted infections to the increased risk of
developing prostate cancer. African American men with a history of sexually transmitted …

Prostate cancer is the second most diagnosed cancer in men and relapse due to the
metastasis of cancer cells is the main reason of the high number of deaths in prostate cancer …

Most genome-wide association studies (GWAS) were analyzed using single marker tests in
combination with stringent correction procedures for multiple testing. Thus, a substantial …

Prostate cancer is the leading cause of non-cutaneous malignancy and is the second most
commonly diagnosed cancer among men after lung cancer. QRFP is a secreted protein that …